Saturday 17 October 2026 Export RGEN’s income statement to Excel — free account

Repligen Corporation

RGEN Healthcare Medical Instruments & Supplies

Repligen Corporation’s revenue for fiscal 2025 (year ended December 2025) was $738.3 million, up 16.4% from fiscal 2024. In the quarter to June 2026, revenue grew 11.9%, EPS fell 65.4%, free cash flow grew 27.1% and total debt rose 3.25%, each against the same quarter a year earlier.

175.20 8.97 −4.87%

Follow RGEN

Alert me

Market cap: $11.7B
P/E: 234×
Fwd P/E: 112×
Dividend yield: —
F-score: 6/9
Altman Z: 7.49
Beneish M: −2.52
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
P/E ratio Full definition →	181.92	128.07	188.34	4,455.67	+8 more quarters Free account
P/S ratio Full definition →	9.80	8.70	12.48	10.62
P/FCF ratio Full definition →	126.01	119.86	215.98	134.37
P/Operating CF Full definition →	234.93	234.66	358.49	156.36
P/B ratio Full definition →	3.64	3.15	4.38	3.61
Price to Tangible BV Full definition →	11.84	10.53	15.22	13.08
EV/Sales Full definition →	9.56	8.48	12.27	10.42
EV/EBITDA Full definition →	46.62	40.12	60.17	78.27
EV/Operating CF Full definition →	55.67	49.51	77.15	56.38
EV/FCF Full definition →	122.90	116.82	212.32	131.85
Quick Ratio Full definition →	7.30	7.42	6.82	6.85
Current Ratio Full definition →	9.05	9.20	8.37	8.36
Net Debt/EBITDA Full definition →	(5.52)	(5.94)	(5.35)	(6.62)
Debt/Assets Full definition →	18.68%	18.65%	18.38%	18.40%
Debt/Equity Full definition →	0.26	0.26	0.26	0.26
Asset Turnover Full definition →	0.27	0.26	0.26	0.25
Operating CF/Net income Full definition →	6.54	3.40	1.93	3.23
Capex/Depreciation Full definition →	(0.18)	(0.20)	(0.33)	(0.36)
Interest Coverage Full definition →	2.47	2.86	3.25	3.11
Research and Development Expense of Revenue Full definition →	7.06%	7.44%	7.03%	7.51%
Selling, General and Administrative Expense of Revenue Full definition →	37.53%	39.40%	38.01%	39.02%
Intangible Assets out of Total Assets Full definition →	0.50	0.50	0.51	0.52
Share Based Compensation of Revenue Full definition →	3.93%	4.28%	4.03%	4.75%
Graham Net Nets Full definition →	0.05	0.05	0.03	0.03
Graham Number Full definition →	25.13	27.81	27.08	5.00
Earnings Yield Full definition →	0.55%	0.78%	0.53%	0.02%
Free Cash Flow Yield Full definition →	0.79%	0.83%	0.46%	0.74%
Revenue per Share Full definition →	3.62	3.45	3.52	3.36
Operating CF per Share Full definition →	0.58	0.50	0.46	0.85
Capex per Share Full definition →	(0.11)	(0.09)	(0.14)	(0.10)
Free Cash Flow per Share Full definition →	0.47	0.41	0.31	0.76
Cash per Share Full definition →	14.37	13.92	13.65	13.31
Shareholders Equity per Share Full definition →	37.44	37.36	37.45	37.02
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	37.44	37.36	37.45	37.02
Free Cash Flow Full definition →	26.70	23.35	17.59	42.71
Working Capital Full definition →	1,067.90	1,035.15	1,001.56	965.35
Capital Expenditures Full definition →	(6.07)	(4.95)	(8.11)	(5.39)
Net Current Asset Value Full definition →	362.41	336.05	293.82	255.86
EV/EBIT Full definition →	116.20	100.28	164.20	9,247.62
Capex to Sales Full definition →	0.03	0.03	0.04	0.03
Price to Operating Income Full definition →	119.14	102.89	167.03	9,424.74
Other line items
Average Receivables Full definition →	157.33	149.48	146.35	139.00
Average Payables Full definition →	29.43	30.80	31.07	25.39
Average Inventory Full definition →	171.23	166.18	156.71	171.39
Average Assets Full definition →	2,925.90	2,891.46	2,889.68	2,877.18
Average Common Equity Full definition →	2,086.89	2,045.47	2,039.42	2,049.89

Show all line items

Columns are period end dates

Stockrow Weekly